The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 11, 2013
Filed:
Jan. 11, 2011
Srinivasan Babu, San Diego, CA (US);
Phillippe Bergeron, Oakland, CA (US);
Peter Dragovich, San Diego, CA (US);
Hazel Joan Dyke, Storrington, GB;
Paul Gibbons, San Francisco, CA (US);
Stefan Gradl, Princeton, NJ (US);
Emily Hanan, Redwood City, CA (US);
Christopher Hurley, Welwyn Garden City, GB;
Tony Johnson, Soham, GB;
Michael Koehler, Palo Alto, CA (US);
Janusz Kulagowski, Sawbridgeworth, GB;
Sharada Labadie, Sunnyvale, CA (US);
Joseph Lyssikatos, Piedmont, CA (US);
Rohan Mendonca, Pleasanton, CA (US);
Rebecca Pulk, San Francisco, CA (US);
Stuart Ward, Royston, GB;
Bohdan Waszkowycz, Macclesfield, GB;
Mark Zak, San Mateo, CA (US);
Srinivasan Babu, San Diego, CA (US);
Phillippe Bergeron, Oakland, CA (US);
Peter Dragovich, San Diego, CA (US);
Hazel Joan Dyke, Storrington, GB;
Paul Gibbons, San Francisco, CA (US);
Stefan Gradl, Princeton, NJ (US);
Emily Hanan, Redwood City, CA (US);
Christopher Hurley, Welwyn Garden City, GB;
Tony Johnson, Soham, GB;
Michael Koehler, Palo Alto, CA (US);
Janusz Kulagowski, Sawbridgeworth, GB;
Sharada Labadie, Sunnyvale, CA (US);
Joseph Lyssikatos, Piedmont, CA (US);
Rohan Mendonca, Pleasanton, CA (US);
Rebecca Pulk, San Francisco, CA (US);
Stuart Ward, Royston, GB;
Bohdan Waszkowycz, Macclesfield, GB;
Mark Zak, San Mateo, CA (US);
Genentech, Inc., South San Francisco, CA (US);
Abstract
The invention provides novel compounds of formula I having the general formula: wherein R, R, R, X and Y are as described herein. Accordingly, the compounds may be provided in pharmaceutically acceptable compositions and used for the treatment of immunological or hyperproliferative disorders.